TRAF3 and neoplasm: The high expression of both plasma membrane S1P1 receptor and cytoplasmic Y216 phosphorylated c-SRC or phosphorylated c-RAF-1 in the same tumor from ER+ breast cancer patients is associated with shorter recurrence time (Ohotski et al., 2012a).